“LY333328 versus Vancomycin in Skin/Skin-structure Infections”, Eli Lilly, University of Pittsburgh Principle Investigator, 1999-2000. Goal was to compare a new antibiotic (LY333328 to vancomycin in terms of efficacy for complicated skin infections
“Prophylactic Antibiotics in the Management of Tube Thoracostomy for Traumatic Hemopneumothorax (PAMOTTTH study)”, Eastern Association for the Surgery of Trauma, 1999-present. Goal is to determine if prophylactic antibiotics are beneficial for patients who require chest tubes for trauma.
“Novel Resuscitation from Lethal Hemorrhagic Shock”, Office of Naval Research, 2000-present. Goal is to develop novel resuscitation strategies to improve outcome from prolonged hemorrhagic shock.
“Novel Resuscitation from Lethal Hemorrhage. Suspended Animation for Delayed Resuscitation”, US Army-Combat Casualty Care, 2000-present. Goal is to develop a novel resuscitation strategy called suspended animation that can preserve the exsanguinated trauma victim until delayed resuscitation and surgery are possible.
“A Prospective, Randomized, Double-Blind, Multicenter Trial Assessing the Safety and Efficacy of Sequential (Intravenous/Oral) BAY 12-8039 (Moxifloxacin) 400 Mg every 24 hours Compared to Intravenous Piperacillin/Tazobactam 3.375 Grams every 6 Hours Followed by Oral Amoxicillin/Clavulanic Acid Suspension 800 Mg every 12 Hours for the Treatment of Patients with Complicated Intra-abdominal Infections.”, Bayer, University of Pittsburgh Principle Investigator, 2000-present. Goal is compare a new quinolone with standard antibiotics for the treatment of patients with complicated intra-abdominal infections.